Search - tctmd.com

Displaying 141 - 160 of 849

Sort: Relevancy | Date

Presentation NY Valves 2024

Designing Trials to Assess the Effectiveness of New VHD Screening Strategies

Presenter: Timothy Joseph Poterucha

June 06, 2024

Presentation NY Valves 2024

Long-term Follow-up in VHD Clinical Trials: Much Needed, BUT Difficult to Do

Presenter: Mauro Moscucci

June 06, 2024

News Conference News NY Valves 2024

Embolic Protection May Help During TAVI, but Stroke Impact Likely Small

Todd Neale

June 05, 2024

Presentation NY Valves 2024

Requirements for GDMT in UPSTREAM AVR Clinical Trials in (1) Preserved EF or (2) Reduced EF Patients

Presenter: Parag Goyal

June 05, 2024

News Conference News NY Valves 2024

Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli

Michael O'Riordan

June 05, 2024

Presentation NY Valves 2024

Phenotypic Diversity in Secondary Mitral Regurgitation: Differential Outcomes Following Transcatheter Edge-to-Edge Repair - Insights From the COAPT and MITRA-FR Trials

Presenter: Guillaume Bonnet

June 05, 2024

Presentation NY Valves 2024

Practical Tips for Cerebral Embolic Protection: From Clinical Trials to Clinical Practice

Presenter: Amar Krishnaswamy

June 05, 2024

Presentation NY Valves 2024

Late Clinical Outcomes With Balloon Expandable Valves in Small Annulus Patients From the PARTNER Trials

Presenter: Rebecca T. Hahn

June 05, 2024

Presentation NY Valves 2024

Impact of Cerebral Embolic Protection Devices on Disabling Stroke After Transcatheter Aortic Valve Replacement: Results From the STS/ACC TVT Registry

Presenter: Neel Butala

June 05, 2024

Presentation NY Valves 2024

Predictors of Bioprosthetic Valve Dysfunction From the Randomized SMART Trial

Presenter: Howard C. Herrmann

June 05, 2024

Presentation NY Valves 2024

A Randomized Comparison of TAVR and SAVR in Low-Risk Patients Aged 70 Years or Younger: Results From the NOTION-2 Trial

Presenter: Ole De Backer

June 05, 2024

News Conference News ESOC 2024

Medicare Analysis Suggests Benefit of PFO Closure Beyond Age 60

Todd Neale

May 17, 2024

News Conference News EuroPCR 2024

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

Michael O'Riordan

May 16, 2024

News Conference News EuroPCR 2024

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

Shelley Wood

May 16, 2024

News Conference News EuroPCR 2024

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

Michael O'Riordan

May 15, 2024

News Conference News EuroPCR 2024

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

Shelley Wood

May 15, 2024

News Conference News EuroPCR 2024

Debate Continues on TAVI Choice for Women With Small Annuli

Yael L. Maxwell

May 14, 2024

News Conference News ESC Heart Failure 2024

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Michael O'Riordan

May 13, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Conference News

TAVI Use Rising in Young US Patients, Yet Another Analysis Shows

Yael L. Maxwell

May 06, 2024

Advertisement

Designing Trials to Assess the Effectiveness of New VHD Screening Strategies

Long-term Follow-up in VHD Clinical Trials: Much Needed, BUT Difficult to Do

Embolic Protection May Help During TAVI, but Stroke Impact Likely Small

Requirements for GDMT in UPSTREAM AVR Clinical Trials in (1) Preserved EF or (2) Reduced EF Patients

Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli

Phenotypic Diversity in Secondary Mitral Regurgitation: Differential Outcomes Following Transcatheter Edge-to-Edge Repair - Insights From the COAPT and MITRA-FR Trials

Practical Tips for Cerebral Embolic Protection: From Clinical Trials to Clinical Practice

Late Clinical Outcomes With Balloon Expandable Valves in Small Annulus Patients From the PARTNER Trials

Impact of Cerebral Embolic Protection Devices on Disabling Stroke After Transcatheter Aortic Valve Replacement: Results From the STS/ACC TVT Registry

Predictors of Bioprosthetic Valve Dysfunction From the Randomized SMART Trial

A Randomized Comparison of TAVR and SAVR in Low-Risk Patients Aged 70 Years or Younger: Results From the NOTION-2 Trial

Medicare Analysis Suggests Benefit of PFO Closure Beyond Age 60

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter?

Debate Continues on TAVI Choice for Women With Small Annuli

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

TAVI Use Rising in Young US Patients, Yet Another Analysis Shows

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content